New Pharmaceutical Labeling Rules Proposed in Brazil
Friday, April 10th, 2009Brazil’s National Sanitary Vigilance Agency (ANVISA) is proposing changes in package labeling rules for pharmaceuticals sold in that country (as set out in ANVISA Resolution RDC 333/03) with a view to making pack labels more informative to consumers. For example, the proposals released for public consultation (until 11 May) would make medicines with a sedative […]
The Need to Improve the Safety of Children’s Medicines
Friday, September 28th, 2007Pharmacovigilance and medicine safety issues in children are relevant to everyone who has an interest in and cares about the health of children. In order to gain full marketing authorization, the law in most countries requires pharmaceutical firms to demonstrate that they have tested their medicines in healthy volunteers and patients for possible adverse effects. […]